Anesthetic management of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS/HIPEC): The importance of hydro-electrolytic and acid-basic control

about

Anesthetic management of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS/HIPEC): The importance of hydro-electrolytic and acid-basic control

Item

http://www.wikidata.org/entity/Q41026582

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Anesthetic management of Cytor ...... rolytic and acid-basic control

@en

type

Item

label

Anesthetic management of Cytor ...... rolytic and acid-basic control

@en

prefLabel

Anesthetic management of Cytor ...... rolytic and acid-basic control

@en

P1476

Anesthetic management of Cytor ...... rolytic and acid-basic control

@en

P2093

Fabrício Tavares Mendonça

http://www.w3.org/2001/XMLSchema#string

Marília Moreira Guimarães

http://www.w3.org/2001/XMLSchema#string

Rúbia Garcia Dusi

http://www.w3.org/2001/XMLSchema#string

Sérgio Honorato de Matos

http://www.w3.org/2001/XMLSchema#string

P2860

Intensive insulin therapy in critically ill patients

Identifying and meeting the challenges of insulin therapy in type 2 diabetes.

Intensive insulin therapy in the medical ICU.

Influence of tidal volume on pulse pressure variation and stroke volume variation during experimental intra-abdominal hypertension.

Hypoglycemia in hospitalized adult patients without diabetes.

Cytoreductive surgery and continuous hyperthermic peritoneal perfusion in patients with mesothelioma and peritoneal carcinomatosis: hemodynamic, metabolic, and anesthetic considerations

Clinical review: Intensive insulin therapy in critically ill patients: NICE-SUGAR or Leuven blood glucose target?

The surgically induced stress response.

Dual stimulus of hyperthermia and intracellular redox environment triggered release of siRNA for tumor-specific therapy.

Hydration with 15 mEq Magnesium Is Effective at Reducingthe Risk for Cisplatin-induced Nephrotoxicity in Patients Receiving Cisplatin (≥50 mg/m2) Combination Chemotherapy.

P304

1-4

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

case report

P356

10.1016/J.IJSCR.2017.07.011

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-07-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28719887

http://www.w3.org/2001/XMLSchema#string

P932

5512179

http://www.w3.org/2001/XMLSchema#string